Cargando…
Reproducibility of in-home CFRD screening using continuous glucose monitoring and mixed meal tolerance test
BACKGROUND: Cystic fibrosis related diabetes (CFRD) is associated with insulin-remediable pulmonary decline, so early detection is critical. Continuous glucose monitors (CGM) have shown promise in screening but are not recommended by clinical practice guidelines. Little is known about the reproducib...
Autores principales: | Kutney, Katherine, Kaminski, Beth A., Casey, Terri, O'Riordan, MaryAnn, Gubitosi-Klug, Rose |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10495624/ https://www.ncbi.nlm.nih.gov/pubmed/37705602 http://dx.doi.org/10.1016/j.jcte.2023.100323 |
Ejemplares similares
-
Lumacaftor/ivacaftor therapy is associated with reduced hepatic steatosis in cystic fibrosis patients
por: Kutney, Katherine, et al.
Publicado: (2019) -
Cystic fibrosis related diabetes (CFRD) prognosis
por: Sandouk, Zahrae, et al.
Publicado: (2021) -
Cystic Fibrosis-Related Diabetes (CFRD): Overview of Associated Genetic Factors
por: Iafusco, Fernanda, et al.
Publicado: (2021) -
MON-097 Continuous Glucose Monitoring in Youth with Type 1 Diabetes; Parental Anxiety and Parent Defined Outcomes: Results of Follow up Surveys
por: Alkhaled, Lina, et al.
Publicado: (2020) -
Predicting glycemic control status and high blood glucose levels through voice characteristic analysis in patients with cystic fibrosis-related diabetes (CFRD)
por: Suppakitjanusant, Pichatorn, et al.
Publicado: (2023)